Andre joined the Board of Oxford Science Enterprises in early 2020, an experienced Deep Tech advisor with an extensive background in investment banking.
Andre was previously Managing Director, Global Head of Equity Trading at Deutsche Bank, where he worked from 1994 to 2016. After leaving investment banking, Andre founded Braavos Partners, an early- to growth-stage venture capital firm.
He currently sits on the Board of Next Biosciences and was previously on the Boards of Deep Science Ventures, Sygnia Asset Management and Genesis Genetics.
